前往化源商城

Biochimica et Biophysica Acta 2015-02-01

Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism.

R Preston Mason, Robert F Jacob

文献索引:Biochim. Biophys. Acta 1848(2) , 502-9, (2014)

全文:HTML全文

摘要

Lipid oxidation leads to endothelial dysfunction, inflammation, and foam cell formation during atherogenesis. Glucose also contributes to lipid oxidation and promotes pathologic changes in membrane structural organization, including the development of cholesterol crystalline domains. In this study, we tested the comparative effects of eicosapentaenoic acid (EPA), an omega-3 fatty acid indicated for the treatment of very high triglyceride (TG) levels, and other TG-lowering agents (fenofibrate, niacin, and gemfibrozil) on lipid oxidation in human low-density lipoprotein (LDL) as well as membrane lipid vesicles prepared in the presence of glucose (200 mg/dL). We also examined the antioxidant effects of EPA in combination with atorvastatin o-hydroxy (active) metabolite (ATM). Glucose-induced changes in membrane structural organization were measured using small angle x-ray scattering approaches and correlated with changes in lipid hydroperoxide (LOOH) levels. EPA was found to inhibit LDL oxidation in a dose-dependent manner (1.0-10.0 µM) and was distinguished from the other TG-lowering agents, which had no significant effect as compared to vehicle treatment alone. Similar effects were observed in membrane lipid vesicles exposed to hyperglycemic conditions. The antioxidant activity of EPA, as observed in glucose-treated vesicles, was significantly enhanced in combination with ATM. Glucose treatment produced highly-ordered, membrane-restricted, cholesterol crystalline domains, which correlated with increased LOOH levels. Of the agents tested in this study, only EPA inhibited glucose-induced cholesterol domain formation. These data demonstrate that EPA, at pharmacologic levels, inhibits hyperglycemia-induced changes in membrane lipid structural organization through a potent antioxidant mechanism associated with its distinct, physicochemical interactions with the membrane bilayer.Copyright © 2014. Published by Elsevier B.V.

相关化合物

结构式 名称/CAS号 全部文献
乙醇 结构式 乙醇
CAS:64-17-5
吉非罗齐 结构式 吉非罗齐
CAS:25812-30-0
烟酸 结构式 烟酸
CAS:59-67-6
非诺贝特 结构式 非诺贝特
CAS:49562-28-9
DL-α-生育酚 结构式 DL-α-生育酚
CAS:10191-41-0
胆固醇 结构式 胆固醇
CAS:57-88-5
维生素E油 结构式 维生素E油
CAS:59-02-9
1,2-二亚油酰基-sn-甘油-3-磷酸胆碱 结构式 1,2-二亚油酰基-sn-甘油-3-磷酸胆碱
CAS:998-06-1